The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host’s previous exposure to similar epitopes on unrelated antigens

References

1. Chiodi F., Mathiesen T., Albert J., Parks E., Norrby E., Wahren B. 1989; IgG subclass responses to a transmembrane protein (gp41) peptide in HIV infection. Journal of Immunology 142:3809–3814
   [Google Scholar]
2. Dalgleish A. G., Chanh T. C., Kennedy R. C., Kanda P., Clapham P., Weiss R. A. 1988; Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide. Virology 165:209–215
   [Google Scholar]
3. Desrosiers R. C., Wyand M. S., Kodoma T., Ringler D. J., Arthur L. O., Sehgal P. K., Letvin N. L., King N. W., Daniel M. D. 1989; Vaccine protection against simian immunodeficiency virus infection. Proceedings of the Naitonal Academy of Sciences, U.S.A 86:6353–6357
   [Google Scholar]
4. Evans D. J., McKeating J., Meredith J. M., Burke K. L., Katrak K., John A., Ferguson M., Minor P. D., Weiss R. A., Almond J. W. 1989; An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature; London: 339:385–388
   [Google Scholar]
5. Gelderblom H. R., Ozel M., Pauli G. 1989; Morphogenesis and morphology of HIV structure-function relations. Archives of Virology 106:1–13
   [Google Scholar]
6. Gnann J. W., Nelson J. A., Oldstone M. B. A. 1987; Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus. Journal of Virology 61:2639–2641
   [Google Scholar]
7. Ho D. H., Sarngadharan M. G., Hirsch M. S., Schooley R. T., Rota T. R., Kennedy R. C., Chanh T. C., Sato V. L. 1987; Human immunodeficiency virus-neutralizing antibodies recognize several conserved domains on the envelope glycoproteins. Journal of Virology 61:2024–2028
   [Google Scholar]
8. Kennedy R. C., Henkel R. D., Paulett D., Allan J. S., Lee T. H., Essex M., Dreesman G. R. 1986; Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science 231:1556–1559
   [Google Scholar]
9. Kieny M. P., Rautmann G., Schmitt D., Dott K., Wain-Hobson S., Alizon M., Girard M., Chamarer S., Laurent A., Montagnier L., Lecocq J. P. 1986; AIDS virus env protein expressed from a recombinant vaccinia virus. Bio/Technology 4:790–795
   [Google Scholar]
10. Lipman D. J., Pearson W. R. 1985; Rapid and sensitive protein similarity searches. Science 227:1435–1441
    [Google Scholar]
11. Mathiesen T., Sonnerborg A., Von Sydow M., Gaines H., Wahren B. 1988; IgG subclass reactivity against human immunodeficiency virus (HIV) and cytomegalovirus in cerebrospinal fluid and serum from HIV-infected patients. Journal of Medical Virology 25:17–26
    [Google Scholar]
12. Mathiesen T., Chiodi F., Broliden P. -A., Albert J., Houghten R. A., Utter G., Wahren B., Norrby E. 1989a; Analysis of a subclass-restricted HIV-1 gp41 epitope by omission peptides. Immunology 67:1–7
    [Google Scholar]
13. Mathiesen T., Broliden P. -A., Rosen J., Wahren B. 1989b; Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides. Immunology 67:453–459
    [Google Scholar]
14. Matthews T. J., Langlois A. J., Robey W. G., Chang N. T., Gallo R. C., Fischinger P. J., Bolognesi D. P. 1986; Restricted neutralization of divergent human T-lymphocyte virus type III isolates by antibodies to the major envelope glycoprotein. Proceedings of the National Academy of Sciences, U.S.A 83:9707–9713
    [Google Scholar]
15. Murphey-Corb M., Martin L. N., Davison-Fairburn B., Montelaro R. C., Miller M., West M., Ohkawa S., Baskin G. B., Zhang J. -Y., Putney S. D., Allison A. C., Eppstein D. A. 1989; A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 246:1293–1297
    [Google Scholar]
16. Pinter A., Honnen W. J., Tilley S. A., Bona C., Zaghouani H., Gorny M. K., Zolla-Pazner S. 1989; Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. Journal of Virology 63:2674–2679
    [Google Scholar]
17. Sanchez-Pescador R., Power M. D., Barr P. J., Steimer K. S., Stempien M. M., Brown-Shimer S. L., Gee W. W., Renard A., Randolph A., Levy J. A., Dina D., Luciw P. A. 1985; Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science 227:484–492
    [Google Scholar]
18. Schneider J., Kaaden O., Copeland T. D., Oroszlan S., Hunsmann G. 1986; Shedding and interspecies type sero- reactivity of the envelope glycopolypeptide gpl20 of the human immunodeficiency virus. Journal of General Virology 67:2533–2538
    [Google Scholar]
19. Staden R. 1988; Methods to define and locate patterns of motifs in sequences. Cabios 4:53–60
    [Google Scholar]
20. Steimer K. S., Van Nest G. A., Haigwood N. L., Tillson E. M., George-Nascimento C., Barr P. J., Dina D. 1988; Recombinant env and gag polypeptides in characterizing HIV-1-neutralizing antibodies. In Vaccines ’88 pp. 347–355 Ginsberg H., Brown F., Lemer R. A., Chanock R. M. Edited by New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
21. Sundqvist V. -A., Linde A., Kurtu R., Werner A., Helm E. B., Popovic M., Gallo R. C., Wahren B. 1986; Restricted IgG subclass responses to HTLV III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. Journal of Infectious Diseases 153:970–973
    [Google Scholar]